Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Drake

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Clinical Endocrinology|November 26, 2015
Circadian variation in serum cortisol during hydrocortisone replacement is not attributable to changes in cortisol-binding globulin concentrationsT T Chung, K Gunganah, J P Monson, et al.
Annals of the Royal College of Surgeons of England|October 24, 2015
Contemporary surgical treatment of primary hyperparathyroidism without intraoperative parathyroid hormone measurementO A Mownah, G Pafitanis, W M Drake, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2018
Hypothalamitis and severe hypothalamic dysfunction associated with anti-programmed cell death ligand 1 antibody treatmentN Tshuma, N Glynn, J Evanson, et al.
European Journal of Endocrinology|August 3, 2005
Markers of cell proliferation in a GH-producing adenoma of a patient treated with pegvisomantW M Drake, D M Berney, K Kovacs, et al.
The American Journal of Gastroenterology|July 1, 1996
Small bowel intussusception and brown bowel syndrome in association with severe malnutritionW M Drake, T A Winter, S K Price, et al.
Urology|May 20, 1998
The invention of the modern uroflowmeter by Willard M. Drake, Jr at Jefferson Medical CollegeM B Chancellor, D A Rivas, S G Mulholland, et al.
European Journal of Endocrinology|September 2, 2004
Transitional care of GH deficiency: when to stop GH therapyM O Savage, W M Drake, P V Carroll, et al.
Endocrine Reviews|August 9, 2001
Optimizing gh therapy in adults and childrenW M Drake, S J Howell, J P Monson, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
An investigation of the predictors of bone mineral density and response to therapy with alendronate in osteoporotic menW M Drake, D L Kendler, C J Rosen, et al.
Clinical Medicine (London, England)|January 25, 2012
Normocalcaemic tetanyV Sehgal, S Vijayan, S Yasmin, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Clinical Endocrinology|November 26, 2015
Circadian variation in serum cortisol during hydrocortisone replacement is not attributable to changes in cortisol-binding globulin concentrationsT T Chung, K Gunganah, J P Monson, et al.
Annals of the Royal College of Surgeons of England|October 24, 2015
Contemporary surgical treatment of primary hyperparathyroidism without intraoperative parathyroid hormone measurementO A Mownah, G Pafitanis, W M Drake, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2018
Hypothalamitis and severe hypothalamic dysfunction associated with anti-programmed cell death ligand 1 antibody treatmentN Tshuma, N Glynn, J Evanson, et al.
European Journal of Endocrinology|August 3, 2005
Markers of cell proliferation in a GH-producing adenoma of a patient treated with pegvisomantW M Drake, D M Berney, K Kovacs, et al.
The American Journal of Gastroenterology|July 1, 1996
Small bowel intussusception and brown bowel syndrome in association with severe malnutritionW M Drake, T A Winter, S K Price, et al.
Urology|May 20, 1998
The invention of the modern uroflowmeter by Willard M. Drake, Jr at Jefferson Medical CollegeM B Chancellor, D A Rivas, S G Mulholland, et al.
European Journal of Endocrinology|September 2, 2004
Transitional care of GH deficiency: when to stop GH therapyM O Savage, W M Drake, P V Carroll, et al.
Endocrine Reviews|August 9, 2001
Optimizing gh therapy in adults and childrenW M Drake, S J Howell, J P Monson, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
An investigation of the predictors of bone mineral density and response to therapy with alendronate in osteoporotic menW M Drake, D L Kendler, C J Rosen, et al.
Clinical Medicine (London, England)|January 25, 2012
Normocalcaemic tetanyV Sehgal, S Vijayan, S Yasmin, et al.
Pageof 9